ABSTRACT
In the 1980s new applications of implantable pulse generators were developed that required higher power than lithium/iodine batteries could produce efficiently. These included implantable neurological stimulators and implantable drug delivery systems. Most devices of these types have used batteries based on lithium/ thionyl chloride. Recently, these devices have turned increasingly to lithium batteries based on organic electrolytes with higher deliverable energy densities at application rates. These battery systems include lithium/silver vanadium oxide, lithium/carbon monofluoride, and lithium with blends of carbon monofluoride and silver vanadium oxide.
